174 related articles for article (PubMed ID: 35217581)
21. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
[TBL] [Abstract][Full Text] [Related]
22. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
[TBL] [Abstract][Full Text] [Related]
23. Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?
Toyoda T; Yates M; Watts RA
Curr Rheumatol Rep; 2022 Apr; 24(4):111-117. PubMed ID: 35316496
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Plasma Exchange in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Nishimura K; Waki D; Kadoba K; Mukoyama H; Yokota T; Murabe H
Ther Apher Dial; 2019 Jun; 23(3):248-252. PubMed ID: 31033197
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
[TBL] [Abstract][Full Text] [Related]
26. Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis.
Magri SJ; Ugarte-Gil MF; Brance ML; Flores-Suárez LF; Fernández-Ávila DG; Scolnik M; Sato EI; de Souza AWS; Saldarriaga-Rivera LM; Babini AM; Zamora NV; Felquer MLA; Vergara F; Carlevaris L; Scarafia S; Guppy ERS; Unizony S;
Lancet Rheumatol; 2023 Aug; 5(8):e483-e494. PubMed ID: 38251580
[TBL] [Abstract][Full Text] [Related]
27. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
28. Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial.
Furuta S; Sugiyama T; Umibe T; Kaneko Y; Amano K; Kurasawa K; Nakagomi D; Hiraguri M; Hanaoka H; Sato Y; Ikeda K; Nakajima H;
BMJ Open; 2017 Dec; 7(12):e018748. PubMed ID: 29247107
[TBL] [Abstract][Full Text] [Related]
29. Antineutrophilic cytoplasmic antibody-associated vasculitis and the kidney.
Balani S; Kizilbash SJ; Kouri AM
Curr Opin Pediatr; 2022 Apr; 34(2):197-202. PubMed ID: 34923562
[TBL] [Abstract][Full Text] [Related]
30. Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy-A meta-analysis.
Pope V; Sivashanmugathas V; Moodley D; Gunaratnam L; Barra L
Semin Arthritis Rheum; 2023 Jun; 60():152189. PubMed ID: 36931168
[TBL] [Abstract][Full Text] [Related]
31. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis--a 25-year perspective.
Szpirt WM
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i146-9. PubMed ID: 25770166
[TBL] [Abstract][Full Text] [Related]
32. The therapeutic effect of plasma exchange on ANCA-associated vasculitis: A meta-analysis.
Zhu Y; Rao J; Liu L; Ou J; Li W; Xue C
Clin Nephrol; 2021 Jun; 95(6):312-322. PubMed ID: 33749583
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis.
Yamada Y; Harada M; Hara Y; Iwabuchi R; Hashimoto K; Yamamoto S; Kamijo Y
Arthritis Res Ther; 2021 Jan; 23(1):28. PubMed ID: 33446268
[TBL] [Abstract][Full Text] [Related]
34. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis.
Floege J; Jayne DRW; Sanders JF; Tesar V; Balk EM; Gordon CE; Adam G; Tonelli MA; Cheung M; Earley A; Rovin BH
Kidney Int; 2024 Mar; 105(3):447-449. PubMed ID: 38388147
[TBL] [Abstract][Full Text] [Related]
35. Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis.
Nagasaka K; Harigai M; Hagino N; Hara A; Horita T; Hayashi T; Itabashi M; Ito S; Katsumata Y; Kawashima S; Naniwa T; Sada KE; Nango E; Nakayama T; Tsutsumino M; Yamagata K; Homma S; Arimura Y
Mod Rheumatol; 2019 Jan; 29(1):119-129. PubMed ID: 29996690
[TBL] [Abstract][Full Text] [Related]
36. Plasma exchange in ANCA-associated vasculitis: the pro position.
Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
[TBL] [Abstract][Full Text] [Related]
37. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.
Pepper RJ; McAdoo SP; Moran SM; Kelly D; Scott J; Hamour S; Burns A; Griffith M; Galliford J; Levy JB; Cairns TD; Gopaluni S; Jones RB; Jayne D; Little MA; Pusey CD; Salama AD
Rheumatology (Oxford); 2019 Feb; 58(2):260-268. PubMed ID: 30239910
[TBL] [Abstract][Full Text] [Related]
38. New therapeutic strategies in lung vasculitis.
Nasser M; Cottin V
Curr Opin Pulm Med; 2020 Sep; 26(5):496-506. PubMed ID: 32740376
[TBL] [Abstract][Full Text] [Related]
39. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis.
Park PG; Yoo BW; Song JJ; Park YB; Lee SW
BMC Pulm Med; 2020 May; 20(1):147. PubMed ID: 32466756
[TBL] [Abstract][Full Text] [Related]
40. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.
Zand L; Specks U; Sethi S; Fervenza FC
Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
